2017
DOI: 10.1097/pas.0000000000000894
|View full text |Cite
|
Sign up to set email alerts
|

Validation of a Mitotic Index Cutoff as a Prognostic Marker in Undifferentiated Uterine Sarcomas

Abstract: Undifferentiated uterine sarcomas (UUS) are a heterogenous group of high-grade mesenchymal tumors. Although these tumors are highly aggressive, a subset of patients may experience long-term survival. These tumors have previously been divided morphologically into uniform and pleomorphic types. A previous study demonstrated that a mitotic index cutoff of 25 mitoses/10 high-power fields (corresponding to 11.16 mitotic figures/mm) could successfully divide tumors into 2 prognostic groups with significantly differe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
12
1
2

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 22 publications
(18 citation statements)
references
References 19 publications
3
12
1
2
Order By: Relevance
“…The authors propose that undifferentiated uterine sarcoma should be divided by mitotic index into 'mitogenic' and 'NOS' (ie, tumors with mitotic index below the cut-off). Their study reaffirms that a subgroup of patients with 'NOS' undifferentiated uterine sarcoma can achieve long term survival and that better methods of determining prognosis are needed 10. Mitotic index was not a prognostic factor in the current series.…”
Section: Discussionsupporting
confidence: 57%
“…The authors propose that undifferentiated uterine sarcoma should be divided by mitotic index into 'mitogenic' and 'NOS' (ie, tumors with mitotic index below the cut-off). Their study reaffirms that a subgroup of patients with 'NOS' undifferentiated uterine sarcoma can achieve long term survival and that better methods of determining prognosis are needed 10. Mitotic index was not a prognostic factor in the current series.…”
Section: Discussionsupporting
confidence: 57%
“…Patients with SMARCA4‐deficient UUS may benefit from enrolment in ongoing clinical trials using tazemetostat, a selective small molecule EZH2 inhibitor or single or combined anti‐PD‐1 therapy using nivolumab and ipilimumab antibodies . Mitotic index appears to have prognostic significance in all UUS, regardless of genotype, with mitotic activity beyond 25/10 HPF (11.16/mm 2 ) having considerably worse survival outcomes …”
Section: Uusmentioning
confidence: 99%
“…40,41 Mitotic index appears to have prognostic significance in all UUS, regardless of genotype, with mitotic activity beyond 25/10 HPF (11.16/mm 2 ) having considerably worse survival outcomes. 42 Uterine tumour resembling ovarian sex cord tumour Fusions involving growth regulation by estrogen in breast cancer 1 (GREB1) and estrogen receptor 1 (ESR1) genes have recently been detected in UTROSCT, a mesenchymal tumour of uncertain malignant potential that resembles sex cord stromal tumours of the ovary. [43][44][45][46] Both genes encode key proteins that are involved in the sex hormone pathway.…”
Section: Uusmentioning
confidence: 99%
“…Finally, the selected slides were reviewed again at the Karolinska University Hospital. Mitotic rate and grade of nuclear atypia was determined as described previously (12,13). IHC for estrogen receptor and progesterone receptor was performed locally in clinical labs accredited for this analysis.…”
Section: Patient Cohort and Central Reviewmentioning
confidence: 99%
“…Indeed, smooth-muscle tumors have a distinct biology depending upon whether they arise in the gynecologic tract or not (3,5). Previously, our group has demonstrated that division into mitotic index groups has prognostic significance for overall survival (12,13). Other studies have attempted to use atypia to subdivide UUS into "uniform" and "pleomorphic" types (14,15).…”
Section: Introductionmentioning
confidence: 99%